Spyre Therapeutics (SYRE) Q2 2016 Earnings

18AugExpected
Q1 2016
Q2 2016
-177.42
-118.43
-59.43
-0.43

Details

Expected EPS
-0.43
Actual EPS
-0.46
Surprise EPS
-0.03
Surprise Percent
+6.98%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.46 per share for Q2 2016.

0 Comments

Share your thoughts